During the past decade, Katholische Kliniken Ruhrhalbinsel GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Katholische Kliniken Ruhrhalbinsel GmbH" are "Crohn Disease" (2 trials), "Idiopathic Parkinson Disease" (1 trials) and "Non Alcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "Katholische Kliniken Ruhrhalbinsel GmbH" in a lesser frequency.

Most popular intervention types in "Katholische Kliniken Ruhrhalbinsel GmbH" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GED-0301" (2 trials), "Obeticholic Acid" (1 trials), "Safinamide Methanesulfonate" (1 trials) and "Safinamide methanesulfonate matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Katholische Kliniken Ruhrhalbinsel GmbH" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Katholische Kliniken Ruhrhalbinsel GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Katholische Kliniken Ruhrhalbinsel GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Katholische Kliniken Ruhrhalbinsel GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".